Benzinga
Benzinga
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Benzinga
mercredi, octobre 28
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Tango Therapeutics Inc
TNGX
NASDAQ
Liste de surveillance
Get Report
Trade with Public
Get Report
Trade with Public
$22.89
0.70
3.13%
Dern. MÀJ: Oct 27, 5:38 PM
Get Report
Aperçu
Actualités
Prévisions de résultats
Événements
Objectifs de cours
Données financières
Sentiment
Actionnariat
Comparer
Rapport sur les stocks
Tango Therapeutics Financials
Tango Therapeutics (TNGX) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
Crude Oil Surges 4%; SLB Shares Jump Following Upbeat Q3 Earnings
U.S. stocks fell Friday: Dow -1.12%, S&P 500 -0.43%, Nasdaq -0.13%. Energy and oil rose; SLB gained 7% on strong results.
Avi Kapoor
PRO
Tango Therapeutics Q2 EPS $(0.37) Misses $(0.32) Estimate
Tango Therapeutics (NASDAQ:TNGX) reported quarterly losses of $(0.37) per share which missed the analyst consensus estimate of $(0.32) by 15.62 percent. This is a 5.71 percent decrease over losses of $(0.35) per share
Benzinga Newsdesk
Tango Therapeutics Q4 Earnings Summary & Key Takeaways
Benzinga Insights
PRO
Tango Therapeutics Q4 EPS $(0.29) Beats $(0.33) Estimate
Tango Therapeutics (NASDAQ:TNGX) reported quarterly losses of $(0.29) per share which beat the analyst consensus estimate of $(0.33) by 11.04 percent. This is a 9.38 percent increase over losses of $(0.32) per share from
Benzinga Newsdesk
Earnings Scheduled For March 5, 2026
Benzinga Insights
Examining the Future: Tango Therapeutics's Earnings Outlook
Benzinga Insights
